Synteract is a full-service, international CRO

Since 1987, we have been guiding virtual, emerging, and mid-sized biopharma companies across the spectrum of Phase I - IV clinical studies with support services that address their specific needs.

2/12/2019 - 2/13/2019 : Outsourcing in Clinical Trials West Coast Booth # 21 More...

11/15/2018: Synteract has acquired KinderPharm, a specialty pediatric CRO, focused on advancing pediatric drug development across all phases of clinical research. More ...

11/20/2018: 5 Reasons to Work with Synteract For Your Pediatric Clinical Trial - Whether you are looking for small scale support, assistance with a specific service, or complete study design and management, Synteract draws on extensive, end-to-end experience in helping clients efficiently navigate the complexities of pediatric trials and regulatory environments.

Synteract Blog 

12/14/2018: Our experts have the strategies and experience to address the unique challenges rare and orphan trials pose. Find out how we can bring your rare and orphan disease study to life: http://ow.ly/Bcbi50jUbHd

Synteract on LinkedIn

12/13/2018: Thank you for visiting! And thank you for your continued support as we bring #pediatric #clinicaltrials to life! https://t.co/qZ2J4KU3aI

Synteract Twitter Feed
x

Contact Synteract

Tell us how to stay in touch with you:

*Required